June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Establishing a standard method for evaluating efficacy against Acanthamoeba
Author Affiliations & Notes
  • Monica Crary
    Alcon Laboratories, Fort Worth, TX
  • Rhonda Walters
    Alcon Laboratories, Fort Worth, TX
  • John Bartell
    Alcon Laboratories, Fort Worth, TX
  • Manal Gabriel
    Alcon Laboratories, Fort Worth, TX
  • Jagath Kadurugamuwa
    Alcon Laboratories, Fort Worth, TX
  • Bradley Catalone
    Alcon Laboratories, Fort Worth, TX
  • Footnotes
    Commercial Relationships Monica Crary, Alcon Labs (E); Rhonda Walters, Alcon Laboratories (E); John Bartell, Alcon Labs (E); Manal Gabriel, Alcon, A Novartis company (E); Jagath Kadurugamuwa, Alcon Labs (E); Bradley Catalone, Alcon, a Novartis Company (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 508. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Monica Crary, Rhonda Walters, John Bartell, Manal Gabriel, Jagath Kadurugamuwa, Bradley Catalone; Establishing a standard method for evaluating efficacy against Acanthamoeba. Invest. Ophthalmol. Vis. Sci. 2013;54(15):508.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To establish a standard method for Multipurpose Contact Lens Solution (MPS) efficacy testing against Acanthamoeba by identifying and reducing variables.

Methods: Bacterized and axenic cultures of trophozoites were used to determine if culture methods affected MPS efficacy. Cysts that were prepared by starvation with or without Escherichia coli were tested to determine variability in susceptibility to MPS following bacterization. Additionally, the effect of heterogeneous cultures on MPS efficacy was determined by examining the increasing ratios of cysts to trophozoites in axenic cultures that were harvested between 3-7 days of age. Most Probable Number was used for enumeration at different post-test time points to determine the earliest appropriate read date for both cell types. Other variables such as inoculum concentrations and MPS volumes were also examined.

Results: Current recommendations suggest that bacterization of Acanthamoeba is the preferred culture method when evaluating MPS efficacy. However, residual E. coli decreases the available biocide, thereby resulting in variability correlated with bacterial concentration. Current culture methods are limited in their ability to generate homogeneous populations of trophozoites. Axenic trophozoite cultures can contain cysts which contribute to the observed variability of MPS efficacy. Harvesting of trophozoites at 3 days results in a more homogenous population of trophozoites as compared to harvesting at 5 or 7 days. Another variable that contributes to conflicting results in the literature is the duration of incubation prior to enumeration. These studies clearly demonstrate that the minimum incubation period for trophozoites plates is 7 days, whereas for cysts it is 14 days. Earlier time points result in incorrect enumeration. Other potential sources of variability include surface to volume ratio of organisms and MPS.

Conclusions: The maximization of a homogenous population of trophozoites or cysts is necessary to obtain reproducible results when testing MPS efficacy. Variability of test results is affected by the purity of the target cell type. For maximum accuracy, enumeration of cells should not be performed prior to the minimum incubation period. These identified variables have a significant effect on the reproducibility and the performance of MPS against Acanthamoeba.

Keywords: 402 Acanthamoeba • 573 keratitis • 477 contact lens  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.